NCT01184235|Completed
Multidimensional Measurement of Psychopharmacological Treatment Response
Actigraphic, Observational, Psychometric and Biological Measurement of Psychopharmacological Treatment Response
Loading search results
Actigraphic, Observational, Psychometric and Biological Measurement of Psychopharmacological Treatment Response
Sponsor study identifier
observational
44
1 country
1
Study Start
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2011
Actual (reported)Study Completion
August 2011
Actual (reported)The study examines actigraphic, observational, psychometric and associated repeated measurements obtained prior to and during psychopharmacological treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
August 12, 2010
Actual (reported)August 18, 2010
Actual (reported)August 2011
Actual (reported)August 2011
Actual (reported)Actigraphic Measurement
Actigraphic measurements are recorded every 30 seconds during three week measurement periods. The actigraphic measurements will be made utilizing an Actiwatch (AW-64 Phillips-Rispironics, Inc.), placed on the subject's non-dominant wrist. The measurements will occur every thirty seconds for approximately 21 consecutive days. Actigraphic measurements collected at this frequency reflect circadian patterns of interest; discern sleep states and characterize activity and activity patterns.
Three week actigraphic measurement periods
Operationally Defined Observations
Randomly repeated treatment course observational measurements during actigraphic measurement periods
This group will include those receiving or anticipating receiving pharmacological intervention whose primary diagnosis is Autism Spectrum Disorder
This group will include those receiving or anticipating receiving pharmacological intervention whose primary diagnosis is Attention Deficit Hyperactivity Disorder.
This group will include unaffected, non treated first degree relatives of this study's subjects receiving or anticipating receiving pharmacological intervention.
This group will include those receiving or anticipating receiving pharmacological intervention whose primary diagnosis is mood disorder.
This study will include those anticipating or receiving any pharmacological intervention
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Children and adults, male or female receiving or anticipating pharmacological intervention and their non-affected first degree relatives will be invited to participate based on institutional actiwatch availability. Since children are the focus of the Child Psychopharmacology Institute they will be the primary recruitment focus, however, adult subjects may include non-affected first degree relatives or others who represent designated cohort groups and will be accepted based on actiwatch availabilty.
Child Psychopharmacology Institute
Fargo, North Dakota, 58103, United States
B. Duke and D. Staton,
Bill J Duke, M.A., Ph.D.
Child Psychopharmacology Institute
Robert D Staton, Ph.D., M.D.
Child Psychopharmacology Institute
44 participants (actual enrollment reported by the registry).
First Submitted
August 12, 2010
First Posted
August 18, 2010
Study Start
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
Contact the study team to confirm eligibility.
Primary Completion
August 2011
Actual (reported)Study Completion
August 2011
Actual (reported)Last Updated
January 6, 2014
Record last verified: 2014-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: